SCHEMBL7726525

SCHEMBL7726525

CC(C)(C)OC(=O)N1C[C@@H](O)C[C@H]1C(=O)Nc1cnc2ccccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.56
CYP1A2 P05177 1/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C19 P33261 1/20 0.56
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
EPHX2 P34913 1/20 0.46
TRPV1 Q8NER1 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC1 Q13547 2/20 0.45
APOBEC3A P31941 1/20 0.45
APOBEC3G Q9HC16 1/20 0.45
KDM4E B2RXH2 3/20 0.44
HDAC8 Q9BY41 2/20 0.44
HDAC3 O15379 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7728992 1.00 POLB (0.56) POLBCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL7728996 1.00 POLB (0.56) POLBCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL7722254 0.91 POLB (0.46) POLBCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL7722250 0.91 POLB (0.46) POLBCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL7729234 0.82 HDAC4 (0.44) POLBCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL7729236 0.82 HDAC4 (0.41) POLBCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL7729456 0.81 EPHX2 (0.48) POLBCYP1A2CYP3A4CYP2C19EPHX2
SCHEMBL7722280 0.80 SCN9A (0.43) POLBCYP1A2CYP3A4CYP2C19MEN1
SCHEMBL28833970 0.78 EPHX2 (0.60) EPHX2TRPV1HDAC4HDAC1KDM4E
SCHEMBL28834223 0.78 EPHX2 (0.60) EPHX2TRPV1HDAC4HDAC1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed